[1]
Mehmood, F. et al. 2018. IMATINIB IN CHRONIC MYELOID LEUKEMIA: PATIENT-REPORTED SIDE EFFECTS AND THEIR INFLUENCE ON QUALITY OF LIFE: Imatinib in Chronic Myeloid Leukemia. Pakistan Armed Forces Medical Journal. 68, 3 (Oct. 2018), 466–70.